SE411898B - Analogiforfarande for framstellning av oxamidsyraderivat - Google Patents

Analogiforfarande for framstellning av oxamidsyraderivat

Info

Publication number
SE411898B
SE411898B SE7403941A SE7403941A SE411898B SE 411898 B SE411898 B SE 411898B SE 7403941 A SE7403941 A SE 7403941A SE 7403941 A SE7403941 A SE 7403941A SE 411898 B SE411898 B SE 411898B
Authority
SE
Sweden
Prior art keywords
preparation
acid derivatives
oxamic acid
analogy procedure
analogy
Prior art date
Application number
SE7403941A
Other languages
English (en)
Swedish (sv)
Inventor
J H Sellstedt
C J Guinosso
A J Begany
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of SE411898B publication Critical patent/SE411898B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C245/00Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond
    • C07C245/02Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides
    • C07C245/06Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings
    • C07C245/08Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings with the two nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings, e.g. azobenzene
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/20Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38Nitrogen atoms
    • C07D277/44Acylated amino or imino radicals
    • C07D277/46Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
SE7403941A 1973-03-23 1974-03-22 Analogiforfarande for framstellning av oxamidsyraderivat SE411898B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34446673A 1973-03-23 1973-03-23

Publications (1)

Publication Number Publication Date
SE411898B true SE411898B (sv) 1980-02-11

Family

ID=23350656

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7403941A SE411898B (sv) 1973-03-23 1974-03-22 Analogiforfarande for framstellning av oxamidsyraderivat

Country Status (14)

Country Link
JP (1) JPS5920664B2 (ja)
AR (1) AR207563A1 (ja)
BE (1) BE812743A (ja)
CA (1) CA1034118A (ja)
CH (1) CH612914A5 (ja)
DE (1) DE2413966A1 (ja)
EG (1) EG11281A (ja)
ES (1) ES424514A1 (ja)
FI (1) FI61688C (ja)
FR (1) FR2222097B1 (ja)
NL (1) NL7403843A (ja)
PH (1) PH14870A (ja)
SE (1) SE411898B (ja)
ZA (1) ZA74635B (ja)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4011337A (en) * 1975-07-07 1977-03-08 The Upjohn Company Oxamide-oxamic compounds, compositions and methods of use
US4172147A (en) * 1976-11-17 1979-10-23 The Upjohn Company 3,5-Dinitro oxanilic acid ester compounds, compositions and methods
US4119783A (en) * 1977-02-18 1978-10-10 The Upjohn Company 3'Lower alkylcarbonyl oxanilic acid esters
NL7810634A (nl) * 1977-10-28 1979-05-02 May & Baker Ltd Tetrazool-derivaten.
DE3027527A1 (de) 1980-07-19 1982-02-18 Basf Ag, 6700 Ludwigshafen Neue oxamidsaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel
DE3027528A1 (de) * 1980-07-19 1982-02-18 Basf Ag, 6700 Ludwigshafen Ueberbrueckte thiazolyloxamidsaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel
DE3135250A1 (de) * 1981-09-05 1983-03-17 Basf Ag, 6700 Ludwigshafen Tricyclische thiazolyloxamate, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel
FR2546885B1 (fr) * 1983-06-06 1986-02-07 Fabre Sa Pierre Oxamates d'anthranilates fonctionnalises utiles comme medicaments dans le traitement des dermatoses inflammatoires
JPS6112268U (ja) * 1984-06-25 1986-01-24 松下電工株式会社 プリント配線基板
JPH072697B2 (ja) * 1985-05-24 1995-01-18 久光製薬株式会社 新規なオキサニル酸誘導体
US6225329B1 (en) 1998-03-12 2001-05-01 Novo Nordisk A/S Modulators of protein tyrosine phosphatases (PTPases)
WO1999046236A1 (en) * 1998-03-12 1999-09-16 Novo Nordisk A/S Modulators of protein tyrosine phosphatases (ptpases)
ES2395682T3 (es) 2007-08-20 2013-02-14 Symrise Ag Derivados de ácido oxálico y su uso como principios activos refrescantes fisiológicos

Also Published As

Publication number Publication date
FI61688B (fi) 1982-05-31
ZA74635B (en) 1975-09-24
FI61688C (fi) 1982-09-10
FR2222097B1 (ja) 1978-06-30
NL7403843A (ja) 1974-09-25
AR207563A1 (es) 1976-10-15
CH612914A5 (en) 1979-08-31
AU6575374A (en) 1975-08-21
ES424514A1 (es) 1976-06-16
DE2413966A1 (de) 1974-09-26
JPS49135929A (ja) 1974-12-27
CA1034118A (en) 1978-07-04
PH14870A (en) 1982-01-08
EG11281A (en) 1977-05-31
JPS5920664B2 (ja) 1984-05-15
FR2222097A1 (ja) 1974-10-18
BE812743A (fr) 1974-09-23

Similar Documents

Publication Publication Date Title
SE414304B (sv) Estrar av cyklopropankarboxylsyraderivat for pesticidiskt bruk
SE398229B (sv) Forfarande for framstellning av 4-fenoxi-fenoxialkankarbonsyraderivat
SE7908625L (sv) Acetylglykosylmykofenolsyraforeningar for framstellning av glykosylmykofenolsyraforeningar
SE419538B (sv) Analogiforfaranden for framstellning av 2-(n-fenoxfenyl)-propionsyraderivat
SE411898B (sv) Analogiforfarande for framstellning av oxamidsyraderivat
SE420604B (sv) Forfarande for framstellning av oxazolderivat
SE420598B (sv) Analogiforfarande for framstellning av naftalenderivat
SE385698B (sv) Forfarande for framstellning av kinolinettiksyraderivat
SE7712151L (sv) Forfarande for framstellning av linkomycinderivat
NO146596C (no) Fremgangsmaate for fremstilling av 6-deoksytetracykliner
SE413404B (sv) Forfarande for framstellning av pyrazolderivat
SE418085B (sv) Forfarande for framstellning av nya sulfamoylbensoesyraamider
SE399708B (sv) Forfarande for framstellning av tioxanton-2-karboxylsyraderivat
SE417319B (sv) Analogiforfarande for framstellning av ergopeptiner
SE7608956L (sv) Forfarande for framstellning av 2-(fenoxialkyltio)-5-nitroimidazoler
SE420716B (sv) Forfarande for framstellning av nya 2-aminometyl-4,6-diahalogenofenolderivat
SE404801B (sv) Forfaranden for framstellning av nya tiazolderivat
SE420089B (sv) Analogiforfarande for framstellning av fenoxipropylaminderivat (acetofenoner)
SE7613500L (sv) Forfarande for framstellning av cefemderivat
SE402106B (sv) Forfarande for framstellning av nya n-(Ÿ-amino)-alkylanilinderivat
NO139125C (no) Analogifremgangsmaate for fremstilling av cykloheksantetrolderivater
SE7810360L (sv) Forening for framstellning av cefalosporansyraderivat
SE407687B (sv) Forfarande for framstellnig av farmaceutiskt aktiva leurosinderivat
AR209281A1 (es) Procedimiento de preparacion de derivados de ciclopropilfenilpirrolidina
SE409325B (sv) Forfarande for framstellning av kinazolinonderivat